Our 2020 Expert Speaker Faculty

Pioneering Academics

Jay Bradner

President

Novartis Institutes for Biomedical Research

Craig Crews

John C. Malone Professor of MCDB, Chemistry & Pharmacology

Yale University

Alessio Ciulli

Professor of Chemical & Structural Biology

University of Dundee

Matthew Disney

Professor of Chemistry & Neuroscience

Scripps Research

Daniel Nomura

Professor of Chemistry

University of California, Berkeley

Milka Kostic

Program Director of Chemical Biology

Dana-Farber Cancer Institute

Hirokazu Arimoto

Professor

Tohoku University

Dirk Trauner

Professor of Chemistry & Neuroscience

New York University

Shaomeng Wang

Warner-Lambert/Parke-Davis Professor in Medicine; Director of Michigan Center for Therapeutic Innovation

University of Michigan

Daohong Zhou

Professor of Pharmacodynamics & Associate Director for Translation & Drug Development

University of Florida

Thomas Dick

Professor

Hackensack Meridian Health, Center for Discovery and Innovation

Courtney Aldrich

Professor

University of Minnesota

Jan Krönke

Professor

Charité Berlin

Guangrong Zheng

Associate Professor of Medicinal Chemistry

University of Florida

Jin Wang

Associate Professor

Baylor College of Medicine

Ramesh Narayanan

Associate Professor & Director of Center for Cancer Drug Discovery

University of Tennessee

Yonghao Yu

Associate Professor of Biochemistry

UT Southwestern Medical Centre

Nir London

Senior Scientist

The Weizmann Institute of Science

George Burslem

Assistant Professor

University of Pennsylvania

Amit Chouhdary

Assistant Professor

Broad Institute,Harvard Medical School & Brigham and Women’s Hospital

Christina Woo

Assistant Professor

Harvard University

Jun Qi

Assistant Professor of Medicine

Dana-Farber Cancer Institute

Rebecca Beveridge

Chancellor’s Fellow & UKRI Future Leaders Fellow

University of Strathclyde

Ashley Modell

Postdoctoral Associate

Broad Institute,Harvard Medical School & Brigham and Women’s Hospital

Sachini Siriwardena

Postdoctoral Associate

Broad Institute,Harvard Medical School & Brigham and Women’s Hospital

Global Leaders from Pharma & Biotech

Ryan Potts

Executive Director & Head of Induced Proximity Platform

Amgen

Yu Shen

Director of Cancer Biology

AbbVie

John Houston

President & Chief Executive Officer

Arvinas

Scott Edmondson

Director & Head of Boston Oncology Chemistry

AstraZeneca

Philipp Cromm

Discovery Chemist

Bayer

James Tonra

Chief Scientific Officer

BeyondSpring Pharmaceuticals

Frank Mercurio

Chief Scientific Officer

BioTheryx

Stewart Fisher

Chief Scientific Officer

C4 Therapeutics

Michael Plewe

Vice President of Medicinal Chemistry

Cullgen

Bomie Han

Research Advisor

Eli Lilly

Greg Verdine

Chairman, President & Chief Executive Officer

Fog Pharma

James Winkler

Head of Degrader Technology

Frontier Medicines

Ingrid Wertz

Principal Scientist & Project Team Lead

Genentec

Markus Queisser

Scientific Leader

GlaxoSmithKline

Stephanos Ioannidis

Vice President & Head of Chemistry

H3 Biomedicine

Didier Berthelot

Principal Scientist

Janssen Pharmaceuticals

Taavi Neklesa

Vice President of Biology

Halda Therapeutics

Nello Mainolfi

Founder, President & Chief Executive Officer

Kymera Therapeutics

Haojing Rong

Vice President of Pre-Clinical Development

Kymera Therapeutics

Richard Glynne

Chief Scientific Officer

Lycia Therapeutics

Rhamy Zeid

Director of Target Biology

C4 Therapeutics

Amine Sadok

Director of Biology

Monte Rosa Therapeutics

Arthur Sands

Chief Executive Officer

Nurix Therapeutics

Daniel Joo

Vice President of Biology

Oerth Bio

James Schiemer

Senior Scientist

Pfizer

Benedict Cross

Chief Technology Officer

PhoreMost

Kandaswamy Vijayan

Chief Executive Officer

Plexium

Suresh Kumar

Senior Director of Research & Development

Progenra

Kevin Foley

Chief Scientific Officer

Ranok Therapeutics

Matthias Wittwer

DMPK/PD Project Leader

Roche

Ian Churcher

Chief Scientific Officer

Amphista Therapeutics

Laura Itzhaki

Professor & Chief Scientific Officer

University of Cambridge & PolyProx Therapeutics

Innovative Solution Providers

Steve McCloskey

Chief Executive Officer

Nanome

Kaelyn Wilke

Senior Product Manager - Emerging Chemical Synthesis

Millipore Sigma

Danette Daniels

Group Leader of Research & Development

Promega

Agustina Rodriguez-Granillo

Principal Scientist II

Schrödinger

Karteek Kadimisetty

Assistant Director of Research & Development

LifeSensors